Event

Just Announced

This screening includes THE TWILIGHT SAGA: BREAKING DAWN - PART 1

Still image from The Twilight Saga: Breaking Dawn - Part 1.

Date and time:: Sun, Dec 15, 7 pm; $20

Genres:

Rosemary's Baby's got nothing on Renesmee.

Based on Stephanie Meyer's New York Times best-selling novels and spawning a world-wide phenomenon, the Twilight Saga—chosen by students and presented here in their extended editions—adds a dangerous twist to the classic story of star-crossed lovers. This is the marathon of killers, Bella Loca! One $20 ticket gets you access to 11 1/2 hours of eternal teenagers, vampires, wolves, one of the most epic baseball games ever filmed, and a truly glittering cinematic experience. Ticketholders can come and go as they please during the marathon, plus snacks, drinks in resealable/enclosed containers (there are no cupholders in the Cinema!), and finger foods that do not emit a strong odor will be allowed for this special event. Alcohol, cigarettes, electronic cigarettes, and illicit drugs are prohibited at IU Cinema.

A marriage, honeymoon, and the birth of a child (oh my—and what a birth!) bring unforeseen and shocking developments for Bella and Edward and those they love, including new … uh ... complications with Jacob. [125 min; drama, fantasy, romance; English]

"The latest and best of the movies about a girl, her vampire and their impossible, ridiculously appealing—yes, I surrendered—love story." — Manohla Dargis, NY Times

"You can argue about the feminist implications of the movie all day long (call me, I'd love to!), but at least in terms of horror, it seems that Condon and company are finally ready to freak out the tweens, and that makes me happy." — Eliza C. Thompson, Bust Magazine

"It may be impossible for anyone but existing fans to take this seriously, but for the unconverted, it's still a legitimately engaging, gape-worthy nutso spectacle." — Alison Willmore, The A.V. Club

Any film screened at IU Cinema may contain content that viewers find sensitive or upsetting. Visit our Audience Advisories page to learn more.